nach oben

Erschienen in:

01.04.2024 | News item

One lot of methocarbamol injection recalled due to particles

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

The US FDA has published a company announcement from Eugia US LLC advising of the voluntary recall of one lot of Methocarbamol Injection, 1000 mg/10mL, after a customer complaint of white particles floating inside the vial. …

Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial) Due to Presence of White Particles Internet Document : 28 Mar 2024. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-fka-auromedics-pharma-llc-issues-voluntary-nationwide-recall-methocarbamol-injection

Titel: One lot of methocarbamol injection recalled due to particles
Publikationsdatum: 01.04.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55384-x

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

One lot of methocarbamol injection recalled due to particles

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Gentamicin

Aspirin/furosemide/linezolid

Prednisone/Rituximab

Flucloxacillin

Ketamine

Antineoplastics